| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +16,366 | 1.1% | $0.5890 | +$9,640 |
| Sells | 2 | -1,500,000 | 99% | $0.5848 | -$877,150 |
| Net | -1 | -1,483,634 | -98% | -$867,510 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Nasrat A Hakim | CEO, President, Director, 10%+ Owner | $15,288,495 | 29 Mar 2024 | ||
| Douglas Plassche | EVP Operations | $2,364,000 | -$615,000 | -21% | 09 Jan 2026 |
| ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | $129,000 | -$262,150 | -67% | 22 Aug 2025 |
| Barry H. Dash | Director | $118,098 | 22 Nov 2023 | ||
| JEFFREY A. WHITNELL | Director | $116,326 | 22 Nov 2023 | ||
| Davis S. Caskey | Director | $74,804 | 22 Nov 2023 | ||
| Kirko Kirkov | Chief Commercial Officer | $9,639 | +$9,640 | 10 Jul 2025 | |
| Robert C. J. Chen | CFO, Secretary, Treasurer | 16 May 2022 | |||
| Mark N Pellegrino | CFO, Secretary, Treasurer | 01 May 2023 | |||
| Marc Bregman | CFO, Secretary, Treasurer | 17 May 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|